ACAD
Price
$22.20
Change
-$0.30 (-1.33%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
3.72B
33 days until earnings call
AURA
Price
$6.29
Change
-$0.28 (-4.26%)
Updated
Jun 26 closing price
Capitalization
390.01M
41 days until earnings call
Interact to see
Advertisement

ACAD vs AURA

Header iconACAD vs AURA Comparison
Open Charts ACAD vs AURABanner chart's image
ACADIA Pharmaceuticals
Price$22.20
Change-$0.30 (-1.33%)
Volume$22.88K
Capitalization3.72B
Aura Biosciences
Price$6.29
Change-$0.28 (-4.26%)
Volume$129.65K
Capitalization390.01M
ACAD vs AURA Comparison Chart in %
Loading...
ACAD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACAD vs. AURA commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACAD is a Buy and AURA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (ACAD: $22.21 vs. AURA: $6.29)
Brand notoriety: ACAD and AURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACAD: 80% vs. AURA: 62%
Market capitalization -- ACAD: $3.72B vs. AURA: $390.01M
ACAD [@Biotechnology] is valued at $3.72B. AURA’s [@Biotechnology] market capitalization is $390.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACAD’s FA Score shows that 1 FA rating(s) are green whileAURA’s FA Score has 0 green FA rating(s).

  • ACAD’s FA Score: 1 green, 4 red.
  • AURA’s FA Score: 0 green, 5 red.
According to our system of comparison, ACAD is a better buy in the long-term than AURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACAD’s TA Score shows that 4 TA indicator(s) are bullish while AURA’s TA Score has 5 bullish TA indicator(s).

  • ACAD’s TA Score: 4 bullish, 5 bearish.
  • AURA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, AURA is a better buy in the short-term than ACAD.

Price Growth

ACAD (@Biotechnology) experienced а -2.59% price change this week, while AURA (@Biotechnology) price change was +3.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.59%. For the same industry, the average monthly price growth was +34.25%, and the average quarterly price growth was +14.95%.

Reported Earning Dates

ACAD is expected to report earnings on Jul 30, 2025.

AURA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+3.59% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACAD($3.72B) has a higher market cap than AURA($390M). ACAD YTD gains are higher at: 21.035 vs. AURA (-23.479). ACAD has higher annual earnings (EBITDA): 102M vs. AURA (-101.63M). ACAD has more cash in the bank: 682M vs. AURA (128M). AURA has less debt than ACAD: AURA (18.4M) vs ACAD (56M). ACAD has higher revenues than AURA: ACAD (996M) vs AURA (0).
ACADAURAACAD / AURA
Capitalization3.72B390M953%
EBITDA102M-101.63M-100%
Gain YTD21.035-23.479-90%
P/E Ratio16.21N/A-
Revenue996M0-
Total Cash682M128M533%
Total Debt56M18.4M304%
FUNDAMENTALS RATINGS
ACAD: Fundamental Ratings
ACAD
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
26
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACADAURA
RSI
ODDS (%)
Bearish Trend 2 days ago
73%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
60%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 1 day ago
75%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 1 day ago
74%
Advances
ODDS (%)
Bullish Trend 9 days ago
73%
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
72%
Bearish Trend 7 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 1 day ago
80%
Aroon
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 1 day ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
ACAD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IYGIX40.970.19
+0.47%
Macquarie Large Cap Growth Fund I
NEMCX22.34N/A
N/A
Neuberger Berman Emerg Mkts Eq C
JPGSX89.39N/A
N/A
JPMorgan U.S. GARP Equity I
ZSCIX30.70N/A
N/A
Zacks Small-Cap Core Institutional
NWALX34.91N/A
N/A
Nationwide BNY Mellon Dyn US Eq Inc A